Table 1.

The Gleason scores and prostate‐specific antigen (PSA) values in the serum of patients with prostate cancer (Prostate Cancer), patients with benign prostate diseases (BPD), and normal healthy control subjects (Healthy Control)

Sample number	Gleason Score	PSA ng/mL	Protein conc. mg/mL
Prostate Cancer
U106	4 + 5	300.5	61.5
U80	4 + 4	63.64	70.8
U81	4 + 4	5.86	63.6
U102	4 + 4	7.52	69.6
U103	4 + 4	4.92	65.4
U124	4 + 4	25.92	64.4
U77	4 + 3	8.01	69.9
U111	4 + 3	6.08	69.7
U120	4 + 3	18.73	83.7
U12	3 + 4	9.01	73.5
U47	3 + 4	25.07	67.5
U78	3 + 4	5.01	67.0
U86	3 + 4	10.71	65.7
U87	3 + 4	12.27	65.7
U108	3 + 4	56.82	68.6
U112	3 + 4	8.70	67.0
U113	3 + 4	20.51	75.7
U115	3 + 4	5.92	65.6
U118	3 + 4	20.90	69.7
U130	3 + 4	8.15	74.2
U79	3 + 3	7.54	53.7
U104	3 + 3	8.87	66.5
U109	3 + 3	12.25	59.7
U141	3 + 3	9.46	70.2
U143	3 + 2	17.24	81.3
BPD
U44		6.71	64.4
U57		4.95	68.3
U68		10.84	65.6
U72		3.66	61.7
U74		7.41	64.6
U75		4.68	61.6
U76		5.72	58.5
U83		4.75	64.0
U84		6.72	65.0
U101		16.89	66.7
U105		7.95	63.6
U114		18.60	72.2
U119		6.02	74.1
U125		17.43	63.2
U126		11.78	68.9
U127		7.77	76.4
U128		6.65	65.6
U129		6.43	79.3
U136		4.13	90.0
U137		6.47	86.4
U138		6.10	63.6
U140		5.98	67.1
U142		7.24	93.6
U144		6.60	87.8
U145		6.05	69.3
U147		6.05	50.7
U148		4.62	63.4
U149		13.52	63.9
Healthy control
UC1		0.98	67.8
UC2		0.81	67.4
UC3		2.04	71.1
UC4		0.64	65.1
UC5		0.45	77.0
UC6		1.01	69.7
UC7		2.13	68.5
UC8		2.31	67.0
UC9		0.88	66.2
UC10		0.73	68.3